Single-shot HIV vaccine candidate induces neutralizing antibodies for the first time

Scientists at The Wistar Institute have developed an HIV vaccine candidate that achieves something never before observed in ...
Devdiscourse

First Participant Enrolled in African-Led HIV Vaccine Trial BRILLIANT 011

The BRILLIANT 011 trial is testing two next-generation HIV vaccine components—BG505 GT1.1 and 426c.Mod.Core-C4b—administered ...

How HIV researchers overcame setbacks and kept a vaccine trial going

Scientists say research into a vaccine for HIV is further along than it’s ever been.But Trump administration cuts to ...
Medical Xpress

Vaccines can put an end to HIV. African governments must take the lead in developing them

HIV remains a major global public health challenge. Nowhere is this more evident than in southern and eastern Africa, where the majority of people living with HIV reside. Here new HIV infections ...
Fred Hutch

Do we still need an HIV vaccine now that we have a twice-a-year prevention shot?

After decades of research, there is still no cure for the disease HIV causes–AIDS. Each year, HIV infects more than one million people worldwide, and a vaccine remains stubbornly out of reach. Hope, ...
Newsweek

HIV: Supercharged Vaccine Could Protect Well With Just One Dose

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and the ...
Briefly on MSN

Hope arises as Cape Town begins Africa's first HIV vaccine human trial

South Africa launches its first human trial for a new HIV vaccine amid U.S. funding cuts, aiming for a functional cure in the next five to ten years ...
New Atlas

MIT's one-shot vaccine could deliver robust protection from HIV

Researchers at Massachusetts Institute of Technology (MIT) have developed a way to 'supercharge' vaccines to the extent that just a single dose can provide strong protection from HIV. Vaccines ...
Yahoo

Trump's aid cuts stop South African HIV vaccine trials in their tracks

JOHANNESBURG (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from ...
Nature

mRNA vaccines for HIV trigger strong immune response in people

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins. Two vaccine candidates using mRNA technology ...
Healio

Does the world still need an HIV vaccine? Experts say yes

Please provide your email address to receive an email when new articles are posted on . Fifteen years ago, an HIV vaccine trial conducted in Thailand and sponsored by the U.S. Army found something no ...
Bay Area Reporter

Last large HIV vaccine trial fails

The last large HIV vaccine study has been halted ahead of schedule after researchers determined "there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition, ...